New drugs aim to improve thrombolytic treatment and calcium antagonist effects in acral melanoma, suggesting potential benefits for diagnosis and management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Feely et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: